{
    "SPADE_UN_21610": {
        "Sequence Information": {
            "Peptide Name": "Magainin-R1 [F5W]",
            "Sequence": "GIGKWLHSAKKFGKAFVGEIMNS",
            "Sequence Length": 23,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "P11006",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P11006",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Conjugation of Cell-Penetrating Peptides to Antimicrobial Peptides Enhances Antibacterial Activity.",
                    "Pubmed ID": "31572872",
                    "Reference": "ACS Omega. 2019;4:15694-15701",
                    "Author": "Lee H, Lim SI, Shin SH, Lim Y, Koh JW, Yang S",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/31572872"
                },
                {
                    "Title": "Improvement of Therapeutic Index by the Combination of Enhanced Peptide Cationicity and Proline Introduction.",
                    "Pubmed ID": "32786298",
                    "Reference": "ACS Infect Dis. 2020;6:2271-2278",
                    "Author": "Azuma E, Choda N, Odaki M, Yano Y, Matsuzaki K",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/32786298"
                },
                {
                    "Title": "Bacteria-selective synergism between the antimicrobial peptides alpha-helical magainin 2 and cyclic beta-sheet tachyplesin I: toward cocktail therapy",
                    "Pubmed ID": "11724544",
                    "Reference": "Biochemistry. 2001;40:14330-14335",
                    "Author": "Kobayashi S, Hirakura Y, Matsuzaki K",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/11724544"
                },
                {
                    "Title": "Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin.",
                    "Pubmed ID": "32126228",
                    "Reference": "Biochim Biophys Acta. 2020;1862:183228",
                    "Author": "Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/32126228"
                }
            ],
            "Mass": 2505.93,
            "PI": 10.0,
            "Net Charge": 4,
            "Hydrophobicity": -0.08,
            "Frequent Amino Acids": "GKA",
            "Absent Amino Acids": "CDOPQRTUY",
            "Basic Residues": 5,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 9,
            "Polar Residues": 14,
            "Positive Residues": 5,
            "Negative Residues": 1,
            "SPADE ID": "SPADE_UN_21610",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_21610",
                    "Similarity": 1.0,
                    "Sequence": "GIGKWLHSAKKFGKAFVGEIMNS"
                },
                {
                    "SPADE_ID": "SPADE_UN_21611",
                    "Similarity": 1.0,
                    "Sequence": "RRRRRRRRRGGGGIGKWLHSAKKFGKAFVGEIMNS"
                },
                {
                    "SPADE_ID": "SPADE_N_05753",
                    "Similarity": 1.0,
                    "Sequence": "AKKFGKAFVGEIM"
                }
            ],
            "Hemolytic Activity": "Human erythrocytes:2.8% Hemolysis=50 µM,Human embryonic kidney HEK293 cells:97% Killing=100 µM,Human umbilical vein endothelial cells HUVEC:92% Killing=100 µM,Human PBMC:IC50=>=65 µM",
            "Target Organism": "Bacillus subtilis KCTC 3068(MIC=8µM),Staphylococcus aureus KCTC 1621(MIC=16-32µM),Enterococcus faecalis KCTC 2011(MIC=16µM),Staphylococcus epidermidis KCTC 1917(MIC=16µM),Escherichia coli KCTC 1682(MIC=32µM),Salmonella typhimurium KCTC 1926(MIC=16-32µM),Pseudomonas aeruginosa KCTC 1637(MIC=32µM),Proteus vulgaris KCTC 2433(MIC=32-64µM),Escherichia coli ATCC 25922(MIC=8µM),Staphylococcus epidermidis ATCC 12228(MIC=20µM),Escherichia coli ATCC 25922(MIC=20µM),Staphylococcus epidermidis ATCC 12228(MIC=40µM),Jurkat T-cell leukemia(IC50=16.8µM)"
        }
    }
}